Arrowhead Pharmaceuticals Inc ARO-C3 KOL Webinar Transcript
Good afternoon, and welcome to the Arrowhead Pharmaceuticals KOL event. (Operator Instructions) As a reminder, this event is being recorded, and a replay will be made available on the Arrowhead Pharmaceuticals website following the conclusion of the formal presentation.
I would now like to turn the call over to Vince Anzalone, Vice President of Investor Relations at Arrowhead. Please go ahead, Vince.
Thank you, Sarah, and thanks, everybody, for joining us today. Go ahead and click forward, please. So just to remind you all, we will be making forward-looking statements on today's call. So please refer to our SEC filings for risk factors.
Next slide, please. So we've got a really good event today. We've got a great panel from external. Outside of the company, we have Dr. Richard Glassock, from the David Geffen School of Medicine at UCLA. And we also have Dr. Peter Browett, from the University of Auckland School of Medicine.
From the company, we have our Senior Vice President
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |